Danilo Buonsenso, Antoni Noguera-Julian, Rossana Moroni, Angel Hernández-Bartolomé, Nora Fritschi, Laura Lancella, Laura Cursi, Aleix Soler-Garcia, Renate Krüger, Cornelia Feiterna-Sperling, Michela Sali, Andrea Lo Vecchio, Sara Scarano, Alicia Hernanz Lobo, Maria Espiau, Antonio Soriano-Arandes, Benhur Sirvan Cetin, Folke Brinkmann, Iveta Ozere, Fernando Baquero-Artigao, Maria Tsolia, Tiago Milheiro Silva, Matilde Bustillo-Alonso, Andrea Martín Nalda, Margherita Mancini, Anna Starshinova, Nicole Ritz, Svetlana Velizarova, Laura Ferreras-Antolín, Florian Götzinger, Olga Bilogortseva, Vira Chechenyeva, Marc Tebruegge, Begoña Santiago-García
RATIONALE: In 2016, a new interferon-gamma release assay (IGRA) was introduced, QuantiFERON-TB Gold Plus (QFT-Plus), claimed to have improved sensitivity in active tuberculosis (TB). OBJECTIVES: This study aimed to determine the performance of QFT-Plus, compared with previous generation IGRAs and the tuberculin skin test (TST), in children with TB in Europe. METHODS: Multicentre, ambispective cohort study within the Paediatric Tuberculosis Network European Trials Group (ptbnet), a dedicated paediatric TB research network comprising >300 members, capturing TB cases <18 years-of-age diagnosed between January 2009 and December 2019...
October 25, 2022: Thorax